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The 4q deletion syndrome is a rare disorder, with an estimated 
incidence of 1 in 1000001 and approximately 150 patients have 
been reported globally.2 With common clinical presentations 
with craniofacial dysmorphism, cardiac and skeletal defects, 
growth failure and developmental delay, wide spectrum of 
phenotypes in 4q deletion syndrome patients have been de-
scribed in correlations with deletion size, genes and genomic 
environment of the affected region.2 Array-comparative ge-
nomic hybridization (aCGH) has advocated this approach by 
detecting various small genetic aberrations that were neglect-
ed by the conventional chromosomal analysis.3 Herein, we re-
port a case of 4q deletion syndrome confirmed by aCGH which 
detected a novel de novo interstitial deletion of 4q28.3–31.21 
in a 6-year-old boy with mild developmental delay.
The proband, a Korean male, was born at 39 weeks of gesta-
tion by normal vaginal delivery with birth weight of 2460 g, as 
the second son of the parents. Both parents and his brother 
were healthy without any remarkable family history. Even th-
ough no medical or surgical event occurred, the patient could 
only speak single words, such as mother, at 30 months. Bailey 
scales of infant development revealed no specific developmen-
tal delay in the areas of motor, social function and cognition, 
except language, for 20 months delay. On physical examina-
tion, no specific abnormality was found. With little suspicion 
for chromosomal abnormalities, genetic studies were ordered 
to rule out congenital chromosomal disorders for mild langu-
age delay.
Chromosome analysis performed with peripheral blood by 
conventional G-banding technique at 550-band resolution 
revealed the karyotype of 46,XY,inv(9)(p12q13)[20] (Fig. 1A), 
which is generally considered as normal variant karyotype.4 
However, when aCGH with NimbleGen CGX-3 whole-ge-
nome array (Roche NimbleGen, Inc., Madison, WI, USA) was 
performed with Genoglyphix software (Signature Genomics, 
Spokane, WA, USA) for further evaluation, 6 Mb deletion (chr4: 
139151789-145163068) within the region 4q28.3–31.21 was 
detected (Fig. 1B). Consequent chromosome and aCGH stud-
ies in both parents were normal, implying a de novo microde-
letion in the patient.
During follow-up outpatient clinics, he had no additional 
symptoms or signs associated with neurologic dysfunction or 
cardiac problem. Until the day of publication, the patient was 
treated with supportive speech therapies and tolerated well in 
public childcare facilities.
The 4q deletion syndrome is a good example of genetic dis-
orders that have well-established genotype-phenotype corre-
lations. Two recent studies have proposed that 4q35.1 region 
is critical for the 4q syndrome, and that 4q32.2–q34.3 region is 
critical for cardiovascular phenotypes.2,5 Another case report 
presented various clinical features of hypertonia, respiratory 
distress syndrome, and developmental delay with the small-
est deletion (4q31.2–31.22, 1 Mb) described until today.6
In this perspective, our case is important for relatively large 
deletion with only single phenotype (i.e., mild language delay), 
when compared with two previous cases who presented simi-
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lar deletion regions (Fig. 1C). A recent 4q deletion syndrome 
with single gene (PCDH18) deletion on 4q28.3 (1.5 Mb, chr4: 
137417338–138947282) expressed severe developmental de-
lay, seizures, microcephaly, hypoplastic corpus callosum, and 
craniofacial dysmorphims.7 Another case of 4q deletion syn-
drome with deletion region on 4q28.3–31.23 (14 Mb, chr4: 
136127048–150690325) expressed various clinical features; 
growth failure, developmental delay, ventricular septum de-
fect, patent foramen ovale, vascular malformation of lung, cor-
pus callosum dysgenesis and craniofacial dysmorphism.8 In 
contrast to two earlier cases, our case revealed only mildly de-
layed language development until the day of publication. We 
could explain this wide gap of clinical phenotypes among three 
4q syndrome patients with similar deleted regions by analyz-
ing the critical genes for severe phenotypes. Genes such as 
PCDH18, SMAD1, and NR3C2 are located outside of the de-
leted region of our case, but within the encompassing region 
(i.e., chr4:136127048–139151789 and chr4:145163068–
150690325), suggesting as possible major contributor for se-
vere phenotypes in the 4q deletion syndrome including cardiac 
and neurologic defects. This finding is also in line with sugges-
tion that 4q31.2–31.22 region (chr4:145963820–147044764) is 
essential for clinical features in the 4q deletion syndrome.6
Even though there was one previous Korean 4q deletion syn-
drome case with severe agenesis of corpus callosum and neo-
natal death, diagnosed by cytogenetic analysis,9 our case is the 
first Korean 4q deletion syndrome case diagnosed by aCGH 
with clinical symptom. Among 150 previously reported 4q de-
Fig. 1. (A) The G-banded karyotype of the patient. Trypsin-Giemsa banded chromosome analysis at the 550-band level shows a pericentric inversion of 
chromosome 9 (arrow), which is considered as the normal variant commonly seen in normal population. Interestingly, microdeletion in the long arm of 
chromosome 4 was not noticed in the chromosome analysis. (B) The array-comparative genomic hybridization result of the patient. Deletion at the region 
from 4q28.3 to 4q31.21 is observed (red box). The size of deletion fragment was estimated to be 6 Mb (from 139151789 kb to 145163068 kb). (C) Comparison 
of deletion loci and sizes among three 4q deletion cases (present case, case of reference 7, and case of reference 8) within the region 4q28.3-31.23. There 
are 8 deleted genes within the region with possible effects on the phenotypes (i.e., PCDH18, SETD7, ELMOD2, IL15, GAB1, HHIP, SMAD1, and NR3C2). 
Considering the severities of three cases, PCDH18, SMAD1, and NR3C2 are suggested to be major contributors to severe phenotypes in the 4q deletion 
syndrome including cardiac and neurologic defects.
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letion syndrome reports, there were not many Asian patients. 
More cases of Korean 4q deletion syndrome with various clin-
ical features are expected.
In conclusion, we reported a case of 4q deletion syndrome 
with a novel de novo interstitial deletion of 4q28.3–31.21, con-
firmed by aCGH, in a 6-year-old boy with mild developmental 
delay.
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